David R Scholl
Overview
Explore the profile of David R Scholl including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
89
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gillim-Ross L, Taylor J, Scholl D, Ridenour J, Masters P, Wentworth D
J Clin Microbiol
. 2004 Jul;
42(7):3196-206.
PMID: 15243082
The severe acute respiratory syndrome coronavirus (SARS-CoV) is the causative agent of the recent outbreak of severe acute respiratory syndrome. VeroE6 cells, fetal rhesus monkey kidney cells, and human peripheral...
2.
Stranska R, Schuurman R, Scholl D, Jollick J, Shaw C, Loef C, et al.
Antimicrob Agents Chemother
. 2004 May;
48(6):2331-3.
PMID: 15155247
A colorimetric yield reduction assay, ELVIRA (enzyme-linked virus inhibitor reporter assay) HSV, was developed to determine the antiviral drug susceptibilities of herpes simplex virus (HSV). It uses an HSV-inducible reporter...
3.
Marcian D, Ptak R, Voss T, Reynolds R, Pathak A, Chamblin T, et al.
Int Immunopharmacol
. 2002 Dec;
2(12):1703-11.
PMID: 12469944
Quillaja saponins (Q. saponins) are readily hydrolyzed at neutral pH to yield degraded deacylated saponins (DS-saponins). Degradation of Q. saponins resulted in some reduction of their capacity to elicit IgG1,...
4.
St George K, Patel N, Hartwig R, Scholl D, Jollick Jr J, Kauffmann L, et al.
J Clin Virol
. 2001 Dec;
24(1-2):107-15.
PMID: 11744435
Background: The development of new anti-influenza drugs has led to concerns regarding the impact on healthcare costs if they are used indiscriminately. Restricting their use to proven influenza virus infections...